Health
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals – Fintech Zoom
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals –
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individualsResearchers in China have reported phase I/II clinical trial findings showing that the vaccine candidate CoronaVac is well tolerated among older individuals and effectively generates antibody responses against severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
CoronaVac is an inactivated SARS-CoV-2 vaccine developed by Chinese pharmaceutical…
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General10 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging
-
Noosa News17 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050